companydata.dkFORWARD PHARMA A/S: Financial statements 2019
CVR: 28865880
FORWARD PHARMA A/S (CVR 28865880) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -5,969,155 and a net result of DKK -28,465,258 compared with DKK -54,294,876 the year before. Equity amounted to DKK 515,926,854. The solvency ratio was 84.1%. The company had 3 employees in the financial year.
- Gross Profit
- -5,969,155 kr.
- Profit/Loss
- -28,465,258 kr.
- Equity
- 515,926,854 kr.
- Total Assets
- 613,146,265 kr.
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -6 mio. | -28.5 mio. | 515.9 mio. | 3 |
| 2018 | 0 | -7.6 mio. | -54.3 mio. | 534.6 mio. | 3 |
| 2017 | 1.3 mia. | - | 880.2 mio. | 89.4 mio. | - |
| 2016 | - | - | 2 mio. | 189.7 mio. | - |
| 2015 | - | - | -51.1 mio. | 176.7 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2019
FORWARD PHARMA A/S has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK -54,294,876.
About FORWARD PHARMA A/S
FORWARD PHARMA A/S was a Danish company of the type Aktieselskab based in Hellerup, founded in 2005 and dissolved in 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 4 employees. In 2024, the company reported a gross profit of DKK -9,457,909 and a net result of DKK 75,927,645 compared with DKK -3,832,516 the year before. Equity amounted to DKK 488,330,233.